Christopher E Brightling, Ian D Pavord. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Asthma/drug therapyAsthma/immunologyAsthma/physiopathologyBronchial Hyperreactivity/drug therapyBronchial Hyperreactivity/immunologyEosinophilia/drug therapyEosinophilia/immunologyEosinophilia/physiopathologyEosinophils/immunologyFemaleHumansInterleukin-5/administration & dosageInterleukin-5/antagonists & inhibitorsMalePrognosisRisk AssessmentTreatment Outcome
Substances: See more » Interleukin-5
Year: 2004 PMID: 14695110 DOI: 10.1164/ajrccm.169.1.955
Source DB: PubMed Journal: Am J Respir Crit Care Med ISSN: 1073-449X Impact factor: 21.405